---
document_datetime: 2023-09-21 19:17:10
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/beromun-epar-all-authorised-presentations_en.pdf
document_name: beromun-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6857244
conversion_datetime: 2025-12-19 01:14:55.415418
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | Invented name   | Strength   | Pharmaceutical form              | Route of administration                      | Immediate Packaging   | Content   | Pack size   |
|------------------|-----------------|------------|----------------------------------|----------------------------------------------|-----------------------|-----------|-------------|
| EU/1/99/097/001  | Beromun         | 1 mg       | Powder for solution for infusion | Isolated limb perfusion (intra-arterial use) | vial (glass)          | 1 mg      | 4 vials     |